Levi G, Gallo V
J Neurochem. 1981 Jul;37(1):22-31. doi: 10.1111/j.1471-4159.1981.tb05286.x.
The aim of the present paper was to determine whether the release of glutamate from putative "glutamergic" terminals in the cerebellum is influenced by gamma-aminobutyric acid (GABA). In a group of preliminary experiments, we present biochemical evidence in favour of a neurotransmitter role of glutamate in the cerebellum: (1) endogenous glutamate was released from depolarized cerebellar synaptosomal preparations in a Ca2+-dependent away; (2) [14C]glutamate was synthesized from [14C]glutamine in cerebellar synaptosomes, and the newly synthesized [14C]glutamate was released released in a Ca2+-dependent way; (3) the elevation of cyclic GMP elicited by depolarization of cerebellar slices in the presence of Ca2+ was partly reversed by the glutamate antagonist glutamic acid diethyl ester, which probably prevented the interaction of endogenously released glutamate with postsynaptic receptors. GABA and muscimol at low concentrations (2--20 micrometers) potentiated the depolarization-induced release of D-[3H]aspartate (a glutamate analogue which labels the glutamate "reuptake pool") from cerebellar synaptosomes. The effect was concentration dependent and was largely prevented by two GABA antagonists, bicuculline and picrotoxin. The stimulation of D-[3H]aspartate release evoked by muscimol was linearly related to the logarithm of K+ concentration in the depolarizing medium. GABA did not affect the overall release of endogenous glutamate, but potentiated, in a picrotoxin-sensitive manner, the depolarization-evoked release of [14C]glutamate previously synthesized from [14C]glutamine. Since nerve endings are the major site of glutamate synthesis from glutamine, GABA and muscimol appear to exert their stimulatory effect at the level of "glutamergic" nerve terminals, probably after interacting with presynaptic GABA receptors. The possible functional significance of these findings is briefly discussed.
本文的目的是确定小脑假定的“谷氨酸能”终末释放谷氨酸是否受γ-氨基丁酸(GABA)影响。在一组初步实验中,我们提供了支持谷氨酸在小脑中作为神经递质作用的生化证据:(1)内源性谷氨酸从去极化的小脑突触体标本中以钙依赖的方式释放;(2)[14C]谷氨酸在小脑突触体中由[14C]谷氨酰胺合成,新合成的[14C]谷氨酸以钙依赖的方式释放;(3)在存在钙离子的情况下,小脑切片去极化引起的环鸟苷酸升高被谷氨酸拮抗剂谷氨酸二乙酯部分逆转,这可能阻止了内源性释放的谷氨酸与突触后受体的相互作用。低浓度(2 - 20微摩尔)的GABA和蝇蕈醇增强了小脑突触体去极化诱导的D-[3H]天冬氨酸(一种标记谷氨酸“再摄取池”的谷氨酸类似物)的释放。该效应呈浓度依赖性,并且在很大程度上被两种GABA拮抗剂荷包牡丹碱和印防己毒素所阻断。蝇蕈醇引起的D-[3H]天冬氨酸释放的刺激与去极化介质中钾离子浓度的对数呈线性相关。GABA不影响内源性谷氨酸的总体释放,但以印防己毒素敏感的方式增强了先前由[14C]谷氨酰胺合成的[14C]谷氨酸的去极化诱发释放。由于神经末梢是谷氨酰胺合成谷氨酸的主要部位,GABA和蝇蕈醇似乎在“谷氨酸能”神经末梢水平发挥其刺激作用,可能是在与突触前GABA受体相互作用之后。简要讨论了这些发现可能的功能意义。